14-24428945-T-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_001039771.3(CBLN3):ā€‹c.110A>Cā€‹(p.Glu37Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000901 in 1,553,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 32)
Exomes š‘“: 0.0000078 ( 0 hom. )

Consequence

CBLN3
NM_001039771.3 missense

Scores

13
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.60
Variant links:
Genes affected
CBLN3 (HGNC:20146): (cerebellin 3 precursor) Members of the precerebellin family, such as CBLN3, contain a cerebellin motif (see CBLN1; MIM 600432) and a C-terminal C1q signature domain (see MIM 120550) that mediates trimeric assembly of atypical collagen complexes. However, precerebellins do not contain a collagen motif, suggesting that they are not conventional components of the extracellular matrix (Pang et al., 2000 [PubMed 10964938]).[supplied by OMIM, Aug 2009]
KHNYN (HGNC:20166): (KH and NYN domain containing) The protein encoded by this gene contains a ribonuclease NYN domain and belongs to the N4BP1 family. The protein is a cofactor for the zinc finger antiviral protein (ZAP protein) which targets viral RNA for degradation and restricts SARS-CoV-2 infection. [provided by RefSeq, Sep 2021]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.36852795).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CBLN3NM_001039771.3 linkuse as main transcriptc.110A>C p.Glu37Ala missense_variant 1/3 ENST00000267406.11 NP_001034860.1 Q6UW01

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CBLN3ENST00000267406.11 linkuse as main transcriptc.110A>C p.Glu37Ala missense_variant 1/31 NM_001039771.3 ENSP00000267406.6 Q6UW01
CBLN3ENST00000555436.1 linkuse as main transcriptc.148-540A>C intron_variant 3 ENSP00000450935.1 G3V2Y8

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
151986
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000623
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000192
AC:
3
AN:
156576
Hom.:
0
AF XY:
0.0000120
AC XY:
1
AN XY:
83408
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000883
Gnomad SAS exome
AF:
0.0000860
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000785
AC:
11
AN:
1401712
Hom.:
0
Cov.:
33
AF XY:
0.0000116
AC XY:
8
AN XY:
691944
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000558
Gnomad4 SAS exome
AF:
0.0000877
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000344
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
151986
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74230
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000623
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000151
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 18, 2023The c.110A>C (p.E37A) alteration is located in exon 1 (coding exon 1) of the CBLN3 gene. This alteration results from a A to C substitution at nucleotide position 110, causing the glutamic acid (E) at amino acid position 37 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Uncertain
0.079
D
BayesDel_noAF
Uncertain
0.080
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.26
T
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.79
T
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.37
T
MetaSVM
Uncertain
0.092
D
MutationAssessor
Uncertain
2.2
M
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.7
N
REVEL
Uncertain
0.63
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0060
D
Polyphen
0.99
D
Vest4
0.47
MutPred
0.35
Loss of disorder (P = 0.0659);
MVP
0.93
MPC
1.0
ClinPred
0.66
D
GERP RS
5.2
Varity_R
0.24
gMVP
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1451443111; hg19: chr14-24898151; API